MARIA KANTZANOU | Medical | Best Researcher Award

Assoc. Prof. Dr. MARIA KANTZANOU | Medical | Best Researcher Award

Assoc. Prof of Medical Microbiology & Parasitology, Medical School, National and Kapodistrian University of Athens, Greece

Dr. Maria Kantzanou is a distinguished Medical Biopathologist and Associate Professor of Medical Microbiology at the National and Kapodistrian University of Athens, Greece. With a robust background in clinical microbiology and molecular diagnostics, she has significantly contributed to infectious disease research and epidemiology. Known for her leadership roles in national reference centers and academic excellence, Dr. Kantzanou combines clinical practice, teaching, and research to advance public health. 🌟

Publication Profile

🎓 Education Background

Dr. Kantzanou holds a Medical Degree from the National Kapodistrian University of Athens and earned her PhD with excellent honors from the same institution. She specialized in Medical Biopathology (Microbiology) and Public Health-Social Medicine. Additionally, she completed a Master of Science in Health Unit Management at the Hellenic Open University. Her postgraduate experience includes clinical and research fellowship at the University of Oxford, UK. 🎓📜

💼 Professional Experience

Her extensive career spans university hospitals, national reference centers, and private diagnostic laboratories. Highlights include her tenure as Clinical Assistant at Oxford, Consultant at Larissa University Hospital, and Director of the National Retrovirus Reference Center in Athens. Since 2022, she serves as the Responsible Physician-Biopathologist at Eugenidion Hospital. Alongside academic roles, she holds key administrative positions in public health organizations and scientific societies. 🏥🔬

🏅 Awards and Honors

Dr. Kantzanou’s work has earned her national recognition for excellence in research and leadership in infectious disease control. She has been entrusted with numerous administrative responsibilities, including board memberships of Greek health organizations and presidency of the Hellenic Association of Medical Law. Her scientific impact is reflected in a high h-index and numerous invitations as a speaker and coordinator in scientific conferences. 🏆🎖️

🔬 Research Focus

Her research centers on molecular microbiology, epidemiology, and infection prevention. Dr. Kantzanou has specialized in diagnostic molecular techniques such as PCR and RT-PCR for bacterial and viral infections. Her work at the National Retrovirus Reference Center emphasizes HIV/AIDS diagnostics and research. Recent publications cover surgical site infections, viral detection in HIV patients, and infection control in clinical settings. 🧬🦠

✍️ Conclusion

Dr. Maria Kantzanou is a leading figure in medical microbiology, whose academic, clinical, and research contributions profoundly impact infectious disease management and healthcare epidemiology in Greece. Her dedication to teaching and mentoring alongside active participation in healthcare administration showcases her multifaceted expertise and commitment to advancing medical science and public health. 🌍💡

📚 Publication Top Notes

Prevalence of Osteosynthesis Hardware Removal Due to Surgical Site Infections Following Sagittal Split Osteotomy: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine (2025)
DOI: 10.3390/jcm14103558
Cited by multiple articles exploring surgical infection control and maxillofacial surgery outcomes.

Prevalence of HHV-6 Detection Among People Living with HIV: A Systematic Review and Meta-Analysis
Viruses (2025)
DOI: 10.3390/v17040531
Cited extensively in virology and HIV co-infection research.

Prevalence of Surgical Site Infections Following Coronectomy: A Systematic Review and Meta-Analysis
Dentistry Journal (2024)
DOI: 10.3390/dj12120379
Widely referenced in dental surgery and infection prevention studies.

Prevalence of Leishmaniasis among Blood Donors: A Systematic Review and Meta-Analysis
Diseases (2024)
DOI: 10.3390/diseases12070160
Important reference in tropical disease and transfusion medicine research.

Prevalence of surgical site infections following extraction of impacted mandibular third molars: A systematic review and meta-analysis
Journal of Stomatology, Oral and Maxillofacial Surgery (2024)
DOI: 10.1016/j.jormas.2024.101995
PMID: 39084557
Cited in oral surgery and clinical epidemiology literature.

The Existence-Relatedness-Growth Theory for Job Satisfaction and Motivation of Greek National Healthcare Service Employees in the Context of Severe Financial Constraints
Cureus (2024)
DOI: 10.7759/cureus.62738
PMID: 39036167
Relevant in healthcare workforce motivation and management studies.

Prevalence of free flap failure in mandibular osteoradionecrosis reconstruction: a systematic review and meta-analysis
Scientific Reports (2024)
DOI: 10.1038/s41598-024-61862-1
Highly cited in reconstructive surgery and oncology-related infection research.

 

 

Igor Samatoshenkov | Medicine | Best Researcher Award

Mr. Igor Samatoshenkov | Medicine | Best Researcher Award

Vascular surgeon, Uniclinic Brandenburg, Medical school Brandenburg, Germany

Dr. Samatoshenkov Igor Valeryevich  is an accomplished cardiovascular surgeon, innovator, and medical entrepreneur, currently based in Brandenburg, Germany. With an MD and PhD in medical sciences, he has made significant strides in the fields of vascular surgery, regenerative medicine, and gene therapy. He is the founder and CEO of “Angiolife,” a Skolkovo-based biotech company pioneering gene-drug research. As a dedicated academic and clinical expert, Dr. Samatoshenkov has been actively involved in cutting-edge surgical practice, scientific research, and medical education. 🧬💉

Publication Profile

Scopus

ORCID

🎓 Education Background

Dr. Samatoshenkov earned his PhD in 2021 from Kazan Federal University 🎓. His earlier training includes a medical degree from Kazan State Medical University (2009–2015), where he also specialized as a professional medical translator (2012–2014). He pursued advanced phlebology training in endovenous laser obliteration in 2018 in Moscow. His comprehensive education has built a solid foundation for his clinical and research pursuits. 📚🩺

💼 Professional Experience

Dr. Samatoshenkov has over a decade of experience in cardiovascular surgery and medical education. Since 2017, he has been serving in the Department of Cardiosurgery No. 1 and is a graduate student in the Department of Histology, Cytology, and Embryology. From 2015 to 2017, he was an attending physician in the Department of Heart Surgery at the ICDC. He also contributed to academia as an assistant in the Department of Normal Anatomy (2016–2017) and led several student scientific circles from 2011 to 2014. In 2018, he founded “Angiolife,” advancing gene-based therapeutics. 🏥💡

🏆 Awards and Honors

Dr. Samatoshenkov’s innovations have been widely recognized. He won the 2023 National Competition of Innovative Ideas in Medicine by AMTEC Foundation 🏅 and the “Top 50 Innovative Ideas” contest in Tatarstan 🥇. He was a finalist in the 2022 MEDLEADS competition and ranked 2nd in the 2021 All-Russian Intellectual Property contest “Intellect.” He also received accolades from the Academy of Sciences of Tatarstan (2020) and Innopolis Startup Tour (3rd place). 🌟🔬

🔬 Research Focus

Dr. Samatoshenkov’s research spans cardiovascular regeneration, gene and stem cell therapy, and surgical innovation. His pioneering studies in VEGF, ANG, and GDNF gene delivery have opened promising avenues in post-ischemic tissue recovery. His experimental models and cell-mediated delivery techniques are pushing the boundaries of modern medicine. 🧪🧠

🔚 Conclusion

With an exceptional blend of clinical excellence, scientific ingenuity, and entrepreneurial vision, Dr. Igor Samatoshenkov is a leading figure in cardiovascular innovation and regenerative therapy. His mission continues to bridge advanced research with real-world patient solutions. 🌐

📘 Top Publications

  1. Modeling of acute venous lesion of the lower extremities in experiment (2016) – Clinical and Experimental Surgery
    Authors: I.V. Samatoshenkov, B.M. Mirolyubov
    Cited by: —
    Journal Link: Not publicly available online

  2. Effects of direct and indirect delivery of the VEGF gene by cord blood cells to the area of limb ischemia in rats (2017) – Morphological Statements
    Authors: I.V. Samatoshenkov, S.A. Andreev, N.V. Boychuk
    🔗 https://doi.org/10.20340/mv-mn.2017(25).4.14-17
    Cited by: 5+

  3. Comparison of the effectiveness of stimulating angiogenesis in ischemic limbs… (2019) – Creative Cardiology
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.24022/1997-3187-2019-13-3-250-262
    Cited by: 10+

  4. Stimulation of angiogenesis of rat skeletal muscle… (2020) – Morphology
    🔗 https://doi.org/10.34922/AE.2020.157.1.006
    Cited by: 15+

  5. Adenoviral vector delivery of VEGF, angiogenin, and GDNF genes promotes angiogenesis… (2020) – BioNanoScience
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.1007/s12668-019-00688-y
    Cited by: 25+

  6. New experimental model of hind limb ischemia in pot-bellied pigs (2023) – Microvascular Research
    Authors: Igor Samatoshenkov et al.
    🔗 https://doi.org/10.1016/j.mvr.2022.104425
    Cited by: 8+

  7. Combined delivery of the VEGF, ANG, and GDNF genes stimulates angiogenesis and post-ischemic regeneration (2024) – Current Issues in Molecular Biology
    🔗 https://doi.org/10.3390/cimb46080507
    Cited by: 12+